Member | Action | Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unknown |
Posted World Bank Group - Health Systems Flagship - Global Course May 13-24, 2024 – 04.01.24 on Documents
We're excited to share our upcoming Global Flagship course. Date: May 12 – 24, 2024 Time: 7 – 10 AM EDT (3 hours) Duration: 3 hours of training each day for eight days spread over a two-week period. Delivery format: Virtual + Hybrid (some countries may want to convene their participants in a shared space with good bandwidth, this would provide opportunities for group discussion during breakout sessions, also for follow-up Group Work Project discussions on a selected Health Reform) Target Audience: Policy makers, senior and mid-level government officials, academics, civil society organizations, development partners, and World Bank staff Target Regions: LAC, ECA, MNA, and the Africa Regions To better accommodate our global audience, we will continue offering our standard course at 7 AM EDT for LAC, ECA, MNA, and the Africa Regions. Additionally, we are introducing a new course time tailored for our participants in Asia, ensuring everyone has a convenient option. This also allows to more counties to explore the hybrid format. Details on the new course schedule will be provided later. Registration Process: Invitation only - TTLs/Regional Practice manager will recommend potential participants from their region. We recommend 5-20 participants and 1-2 World Bank Staff/Consultants per country. Language: The training is presented live on Zoom in up to 6 languages. We translate all course materials into the selected languages. Usually, we require a minimum of at least 20 participants to request a specific language. English is the default language. The languages for this course will be annonced soon. Budget: The course will be supported by funding from the PHRD TF. Alignment/Justification: The Flagship program is well-established and aligned with the Bank’s learning agenda to offer learning opportunities to both client and staff Curriculum: Please see the draft agenda for course and may be subject to modifications as we get closer to the course delivery dates. The World Bank HNP Health Systems Flagship Course – Draft Agenda Virtual & Hybrid Course May 13-24, 2024 Week 1 (May 13-17)
Week 2 (May 20-24)
|
27 days ago |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Updated World Bank Group - Health Systems Flagship - Global Course May 13-24, 2024 – 04.01.24 on Documents
We're excited to share our upcoming Global Flagship course. Date: May 12 – 24, 2024 Time: 7 – 10 AM EDT (3 hours) Duration: 3 hours of training each day for eight days spread over a two-week period. Delivery format: Virtual + Hybrid (some countries may want to convene their participants in a shared space with good bandwidth, this would provide opportunities for group discussion during breakout sessions, also for follow-up Group Work Project discussions on a selected Health Reform) Target Audience: Policy makers, senior and mid-level government officials, academics, civil society organizations, development partners, and World Bank staff Target Regions: LAC, ECA, MNA, and the Africa Regions To better accommodate our global audience, we will continue offering our standard course at 7 AM EDT for LAC, ECA, MNA, and the Africa Regions. Additionally, we are introducing a new course time tailored for our participants in Asia, ensuring everyone has a convenient option. This also allows to more counties to explore the hybrid format. Details on the new course schedule will be provided later. Registration Process: Invitation only - TTLs/Regional Practice manager will recommend potential participants from their region. We recommend 5-20 participants and 1-2 World Bank Staff/Consultants per country. Language: The training is presented live on Zoom in up to 6 languages. We translate all course materials into the selected languages. Usually, we require a minimum of at least 20 participants to request a specific language. English is the default language. The languages for this course will be annonced soon. Budget: The course will be supported by funding from the PHRD TF. Curriculum: Please see the draft agenda for course below and may be subject to modifications as we get closer to the course delivery dates. The World Bank HNP Health Systems Flagship Course – Draft Agenda Virtual & Hybrid Course May 13-24, 2024 Week 1 (May 13-17)
Week 2 (May 20-24)
|
27 days ago |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Updated Health Systems Flagship Global Core Course - May 13-24, 2024 on Documents
Date: May 13 – 24, 2024 Time: 7 – 10 AM EDT (3 hours) Duration: 3 hours of training each day for eight days spread over a two-week period. Delivery format: Virtual + Hybrid
As we navigate the complexities of global health challenges, including pandemics, conflicts, and economic uncertainties, the imperative for strong health systems is clearer than ever. The World Bank Group, a leading investor in health systems, is committed to equipping you with the knowledge and tools necessary to drive progress towards Universal Health Coverage (UHC).
This interactive course is designed to equip participants with the latest insights from the health sector, promoting a systems approach to effectively tackle health system challenges. Our goal is to stimulate meaningful policy dialogue and build technical capacity, setting the stage for strategic health reforms. The curriculum offers a range of perspectives and practical solutions, empowering participants to confidently navigate and resolve health-related issues.
The course is tailored for policymakers, senior and mid-level government officials, health professionals, and anyone with an interest in the complexities of health systems and their pivotal role in achieving UHC.
Please note that this year's event will be by invitation only, allowing us to better manage participant engagement, course activities, and to maximize the impact of the program. We believe this approach will enhance the learning experience for all attendees. Session recordings may be available upon request. We appreciate your understanding and look forward to a productive and insightful course.
|
27 days ago |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Updated Health Systems Flagship Global Core Course - May 13-24, 2024 on Documents
Date: May 13 – 24, 2024 Time: 7 – 10 AM EDT (3 hours) Duration: 3 hours of training each day for eight days spread over a two-week period. Delivery format: Virtual + Hybrid
As we navigate the complexities of global health challenges, including pandemics, conflicts, and economic uncertainties, the imperative for strong health systems is clearer than ever. The World Bank Group, a leading investor in health systems, is committed to equipping you with the knowledge and tools necessary to drive progress towards Universal Health Coverage (UHC) and other Health Reform Priorities.
This interactive course is designed to equip participants with the latest insights from the health sector, promoting a systems approach to effectively tackle health system challenges. Our goal is to stimulate meaningful policy dialogue and build technical capacity, setting the stage for strategic health reforms. The curriculum offers a range of perspectives and practical solutions, empowering participants to confidently navigate and resolve health-related issues.
The course is tailored for policymakers, senior and mid-level government officials, health professionals, and anyone with an interest in the complexities of health systems and their pivotal role in achieving UHC and priority health reforms.
Please note that this year's event will be by invitation only, allowing us to better manage participant engagement, course activities, and to maximize the impact of the program. We believe this approach will enhance the learning experience for all attendees. Session materials may be available upon request. We appreciate your understanding and look forward to a productive and insightful course.
|
27 days ago |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Posted Change Cannot Wait: Building Resilient Health Systems in the Shadow of COVID-19: Background and Resources on Documents
What is a Resilient Health System – short video and other materials. The COVID-19 pandemic has shown the world that fundamental change in health systems cannot wait. The probability of a pandemic with similar impact to COVID-19 is set to increase three-fold in the next few decades due to increasing risk drivers, such as urbanization, climate change, land use changes, fragility and conflict, and zoonotic spillovers. This report builds on previous work, leverages new research, and considers countries’ frontline experiences during COVID-19. It presents a new framework for making health systems resilient, shows how countries can build them, and where countries and partners can target investments to improve health outcomes. |
Feb 15 2024, 11:09 AM |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Posted Digital-in-Health Flagship Report on Documents
This flagship report Digital-in-Health: Unlocking the Power for Everyone calls for a new digital-in-health approach where digital technology and data are infused into every aspect of health systems management and health service delivery for better health outcomes. The report proposes ten recommendations across three priority areas for governments to invest in: prioritize, connect and scale. |
Feb 15 2024, 11:07 AM |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Posted WHO/WB/BMJ Collection on Quality of Care on Documents
https://www.bmj.com/qualityofcare This newly released BMJ collection on quality of care is jointly developed by the World Bank, the World Health Organization, and the BMJ, featuring 15 insightful articles. This collection provides in-depth analysis of both ongoing challenges and emerging priorities for enhancing the quality of healthcare in low- and middle-income countries. With a primary focus on maternal, newborn, and child health, the articles highlight key issues requiring immediate attention and action. They also explore new and evolving opportunities to ensure universal access to quality health services, addressing both current needs and future possibilities. |
Feb 15 2024, 11:06 AM |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Posted 7th Annual Health Financing Forum on Documents
Join us, on April 15th -17th, for the Annual Health Financing Forum to explore together how countries can prioritize health in government expenditure, allocate more funds to key health programs, elevate health in Official Development Assistance, and make the case for investing in health. Stay tuned for more information and the pre-registration link, which will be available soon! This event is not closed doors but not open widely. Please state that priority for registration will be given to policy makers, and HF practitioners.
Show more
|
Feb 15 2024, 10:53 AM |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unknown |
Posted New malaria vaccines will save lives. How can we ensure a sustainable rollout? on blogs
World Bank Blogs - Published on Investing in Health - New malaria vaccines will save lives. How can we ensure a sustainable rollout?- By CHIJIOKE OKORO, NOEL CHISAKA, CAROLINA KERN - FEB 7, 2024 Last month, Cameroon became the first country to start rolling out malaria vaccination as part of its routine immunization program, with Burkina Faso joining just yesterday. This follows successful malaria vaccine trials in Ghana, Kenya, and Malawi where over 2 million children participated in evaluating RTS, S – one of two WHO-recommended vaccines to fight malaria. According to the Malaria Vaccine Implementation Programme—a body created to assess the public health use of the RTS, S—the vaccine prevents around 75% of malaria episodes when given seasonally in conjunction with other effective malaria interventions. Implementation data also points to a substantial fall in severe malaria hospitalizations and a remarkable (13%) drop in all-cause mortality (i.e., not just from malaria) from use of the vaccine. New tool in the fight against malaria This is big news: malaria is one of the world’s deadliest diseases, killing over half a million people a year, mainly children under five years of age in sub-Saharan Africa. Lower immunity during pregnancy makes it a particularly dangerous disease for women as well, with up 25 million pregnant women affected annually. Malaria has a major impact on families due to the heavy burden it places on households. Treatment is expensive – and must often be sought multiple times a year. It also puts a strain on health systems, especially primary health care services since clinics and dispensaries are the main providers of treatment and prevention interventions. The economic costs of malaria are estimated to be huge – though difficult to quantify precisely due to gaps in data. Malaria causes missed days at work or school, as well as drops in productivity. One estimate suggests that, among countries with intense transmission, malaria reduces GDP growth by up to 1.3%. Against this backdrop, there are several opportunities to support the sustainable rollout of new malaria vaccines, as part of a package of essential interventions.
Malaria control has been an important part of the World Bank’s health portfolio for over three decades. Its experience in supporting health systems – through analytics, technical support, and financing – remains critical to providing support for this new vaccine, as part of routine immunization programs. It is not a simple question of procuring enough doses, though even this isn’t always straightforward. Running a successful immunization program requires health ministries to train healthcare workers and ensure adequate vaccine storage. Robust information systems are also necessary to record vaccine doses delivered and rationalize how they fit with other vaccines that form part of a country’s immunization schedule. Demand generation at community level is a major consideration since RTS, S – also known as Mosquirix – is currently set to be delivered in four doses. While most doses can be given along with other vaccines that fall within current immunization programs, an additional visit will likely be needed to adhere to the recommended regimen. Families will need to be convinced that this extra trip to the clinic is worth it. Combating vaccine hesitancy for other reasons – be it safety or perceived ineffectiveness – is another consideration. There are also questions of how to sequence and coordinate the roll out and how to deliver the vaccine alongside other health and environmental interventions. Complementary control measures such as providing insecticide-treated nets, clearing vegetation, and draining stagnant water must continue to be incorporated as part of malaria control efforts, which means strong collaboration between numerous departments and ministries. This level of multisectoral collaboration may prove challenging given the vertical way in which most vaccine programs are delivered and how difficult it can be to change long established ways of workings.
The World Bank’s support for strengthening planning and resource prioritization is critical in helping countries implement cost-effective and equitable interventions, while considering financial and health systems constraints. This support will be critical given that there is a now a second vaccine – R21/Matrix-M – on the market that is about half the price of RTS, S and is easier to produce, meaning that there are likely to be fewer supply constraints. But even with a cheaper vaccine, there are still likely to be significant financing gaps. In the short term, there may be scope for the World Bank to leverage existing immunization-focused operations to support countries with malaria vaccine delivery (as is the plan in the case in Nigeria) or to look at how broader health systems strengthen programs could play a role. For countries that aren’t receiving vaccine delivery support in the short term, but who would like to introduce malaria vaccines, new World Bank financing could be considered as part of broader system financing. In the longer term, fiscal space analyses will be important as countries navigate the process of moving towards full self-financing of vaccines.
The World Bank is proud to be a founding partner of Gavi, The Vaccine Alliance, who aims to introduce RTS, S in 20 African countries in 2024 reaching over 6 million children. The World Bank works closely with Gavi as a board member and technical partner at country level. In addition, it is part of various global technical teams including the Malaria Vaccine Coordination Team, which is helping countries with their grant applications to Gavi and is also part of broader prioritization discussions. It has also recently committed to stronger collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, whose efforts to strengthen country malaria control/elimination interventions have been critical over the last two decades. Efforts to operationalize this pledge, especially at country level, are currently under way with work set to focus on climate and health, health financing and regional manufacturing – all highly relevant to malaria control. These existing partnerships may provide an entry point to support Gavi and the Global Fund’s recent commitment to optimize the deployment of malaria vaccines ensuring that they are not delivered as a standalone intervention, but in conjunction with other proven, cost-effective measures. |
Feb 14 2024, 2:58 PM |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bruce Summers |
Updated New malaria vaccines will save lives. How can we ensure a sustainable rollout? on blogs
World Bank Blogs - Published on Investing in Health - New malaria vaccines will save lives. How can we ensure a sustainable rollout?- By CHIJIOKE OKORO, NOEL CHISAKA, CAROLINA KERN - FEB 7, 2024 Last month, Cameroon became the first country to start rolling out malaria vaccination as part of its routine immunization program, with Burkina Faso joining just yesterday. This follows successful malaria vaccine trials in Ghana, Kenya, and Malawi where over 2 million children participated in evaluating RTS, S – one of two WHO-recommended vaccines to fight malaria. According to the Malaria Vaccine Implementation Programme—a body created to assess the public health use of the RTS, S—the vaccine prevents around 75% of malaria episodes when given seasonally in conjunction with other effective malaria interventions. Implementation data also points to a substantial fall in severe malaria hospitalizations and a remarkable (13%) drop in all-cause mortality (i.e., not just from malaria) from use of the vaccine. New tool in the fight against malaria This is big news: malaria is one of the world’s deadliest diseases, killing over half a million people a year, mainly children under five years of age in sub-Saharan Africa. Lower immunity during pregnancy makes it a particularly dangerous disease for women as well, with up 25 million pregnant women affected annually. Malaria has a major impact on families due to the heavy burden it places on households. Treatment is expensive – and must often be sought multiple times a year. It also puts a strain on health systems, especially primary health care services since clinics and dispensaries are the main providers of treatment and prevention interventions. The economic costs of malaria are estimated to be huge – though difficult to quantify precisely due to gaps in data. Malaria causes missed days at work or school, as well as drops in productivity. One estimate suggests that, among countries with intense transmission, malaria reduces GDP growth by up to 1.3%. Against this backdrop, there are several opportunities to support the sustainable rollout of new malaria vaccines, as part of a package of essential interventions.
Malaria control has been an important part of the World Bank’s health portfolio for over three decades. Its experience in supporting health systems – through analytics, technical support, and financing – remains critical to providing support for this new vaccine, as part of routine immunization programs. It is not a simple question of procuring enough doses, though even this isn’t always straightforward. Running a successful immunization program requires health ministries to train healthcare workers and ensure adequate vaccine storage. Robust information systems are also necessary to record vaccine doses delivered and rationalize how they fit with other vaccines that form part of a country’s immunization schedule. Demand generation at community level is a major consideration since RTS, S – also known as Mosquirix – is currently set to be delivered in four doses. While most doses can be given along with other vaccines that fall within current immunization programs, an additional visit will likely be needed to adhere to the recommended regimen. Families will need to be convinced that this extra trip to the clinic is worth it. Combating vaccine hesitancy for other reasons – be it safety or perceived ineffectiveness – is another consideration. There are also questions of how to sequence and coordinate the roll out and how to deliver the vaccine alongside other health and environmental interventions. Complementary control measures such as providing insecticide-treated nets, clearing vegetation, and draining stagnant water must continue to be incorporated as part of malaria control efforts, which means strong collaboration between numerous departments and ministries. This level of multisectoral collaboration may prove challenging given the vertical way in which most vaccine programs are delivered and how difficult it can be to change long established ways of workings.
The World Bank’s support for strengthening planning and resource prioritization is critical in helping countries implement cost-effective and equitable interventions, while considering financial and health systems constraints. This support will be critical given that there is a now a second vaccine – R21/Matrix-M – on the market that is about half the price of RTS, S and is easier to produce, meaning that there are likely to be fewer supply constraints. But even with a cheaper vaccine, there are still likely to be significant financing gaps. In the short term, there may be scope for the World Bank to leverage existing immunization-focused operations to support countries with malaria vaccine delivery (as is the plan in the case in Nigeria) or to look at how broader health systems strengthen programs could play a role. For countries that aren’t receiving vaccine delivery support in the short term, but who would like to introduce malaria vaccines, new World Bank financing could be considered as part of broader system financing. In the longer term, fiscal space analyses will be important as countries navigate the process of moving towards full self-financing of vaccines.
The World Bank is proud to be a founding partner of Gavi, The Vaccine Alliance, who aims to introduce RTS, S in 20 African countries in 2024 reaching over 6 million children. The World Bank works closely with Gavi as a board member and technical partner at country level. In addition, it is part of various global technical teams including the Malaria Vaccine Coordination Team, which is helping countries with their grant applications to Gavi and is also part of broader prioritization discussions. It has also recently committed to stronger collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, whose efforts to strengthen country malaria control/elimination interventions have been critical over the last two decades. Efforts to operationalize this pledge, especially at country level, are currently under way with work set to focus on climate and health, health financing and regional manufacturing – all highly relevant to malaria control. These existing partnerships may provide an entry point to support Gavi and the Global Fund’s recent commitment to optimize the deployment of malaria vaccines ensuring that they are not delivered as a standalone intervention, but in conjunction with other proven, cost-effective measures. |
Feb 14 2024, 2:58 PM |